Institute of Medicine Committee on Quality of Health Care. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington: National Academies Press; 2001.
Lemieux J, Goodwin PJ, Bordeleau LJ, Lauzier S, Théberge V. Measurement of quality of life in randomized clinical trials of breast cancer: an updated systematic review (2001-2009). J Natl Cancer Inst. 2011;103(3):178–231.
Marsh EE, Al-Hendy A, Kappus D, Galitsky A, Stewart EA, Kerolous M. Burden, prevalence, and treatment of uterine fibroids: a survey of American women. J Women’s Health (2002). 2018;27(11):1359–67.
Treat LS, Williams VS, Fehnel SE. Development of a daily electronic diary of symptoms of uterine fibroids. Patient. 2011;4(1):31–44.
Egbe TO, Badjang TG, Tchounzou R, Egbe EN, Ngowe MN. Uterine fibroids in pregnancy: prevalence, clinical presentation, associated factors and outcomes at regional hospitals in Limbe and Buea, Cameroon: a cross-sectional study. BMC Resolution Notes. 2018;11(1):889.
Ghant MS, Sengoba KS, Recht H, Cameron KA, Lawson AK, Marsh EE. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women’s emotional and psychosocial health. J Psychosom Res. 2015;78(5):499–503.
Laberge PY, Vilos GA, Vilos AG, Janiszewski PM. Burden of symptomatic uterine fibroids in Canadian women: a cohort study. Current opinion of Res. med. 2016;32(1):165–75.
Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG Int J Obstet Gynaecol. 2017;124(10):1501–12.
Whiteman MK, Kuklina E, Jamieson DJ, Hillis SD, Marchbanks PA. Hospitalization for gynecological disorders in the United States. Am J Obstet Gynecol. 2010;202(6):541.e541-546.
Baird DD, Patchel SA, Saldana TM, Umbach DM, Cooper T, Wegienka G, Harmon QE. Incidence and growth of uterine fibroids in a prospective ultrasound-based study of young African Americans. Am J Obstet Gynecol. 2020;223(3):402.e401-402.e418.
Gabrilove JL, Perez EA, Tomita DK, Rossi G, Cleeland CS. Assessing symptom burden using the MD Anderson Symptom Inventory in patients with chemotherapy-induced anemia: results from an open-label, multicenter study (SURPASS) of patients treated with darbepoetin at a 200 μg dose every 2 weeks. Cancer. 2007;110:1629–40.
Zhou XJ, Zhao ZM, Liu P, Zhao CY, Lin YJ, Liu Y, Wang M, Tian C, Li HY, Hou CX, et al. Effectiveness of high-intensity focused ultrasound treatment for cystic adenomyosis: about four cases. Ann Palliat Med. 2020;9(6):3742–9.
Ma J, Brown B, Liang E. Long-term durability of uterine artery embolization for the treatment of symptomatic adenomyosis. Aust NZJ Obstet Gynaecol. 2021;61(2):290–6.
Tinelli A, Gustapane S, D’Oria O, Licchelli M, Panese G. Nutraceuticals in the management of fibroids after administration of ulipristal acetate: an observational patient compliance study. Int J Gynaecol Obstet. 2021;156:133–8.
Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new questionnaire on disease-specific symptoms and health-related quality of life for leiomyomas. Obstet Gynecol. 2002;99(2):290–300.
Silva RO, Gomes MT, Castro RA, Bonduki CE, Girão MJ. Uterine Fibroid Symptom – Translation and Validation of Quality of Life Questionnaire in Brazilian Portuguese. Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2016;38(10):518–23.
Oliveira Brito LG, Malzone-Lott DA, Sandoval Fagundes MF, Magnani PS, Fernandes Arouca MA, Poli-Neto OB, Nogueira AA. Translation and validation of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire for the Brazilian Portuguese language. Sao Paulo Med J = Revista paulista de medicina. 2017;135(2):107–15.
Calaf J, Palacios S, Cristóbal I, Cañete ML, Monleón J, Fernández J, Hernández A, Vázquez F. Validation of the Spanish version of the Uterine Fibroid Symptom and Quality of Life (UFS-QoL) questionnaire in women with uterine myomatosis . Med Clin. 2020;154(6):207–13.
Yeung SY, Kwok JWK, Law SM, Chung JPW, Chan SSC. Questionnaire on uterine fibroid symptoms and health-related quality of life: a translation and validation study in Chinese. Hong Kong Med J = Xianggang yi xue za zhi. 2019;25(6):453–9.
Wang XQ, Zhu L, Xu T, Zhang L, Lyu T, Chen R. Validation of the Chinese version of uterine fibroid symptom and health-related quality of life. Zhonghua Fu Chan Ke Za Zhi. 2017;52(7):455–60.
Coyne KS, Soliman AM, Margolis MK, Thompson CL, Chwalisz K. Validation of the 4-week recall version of the Uterine Fibroid Symptoms and Health-Related Quality of Life (UFS-QOL) Questionnaire. Current opinion of Res. med. 2017;33(2):193–200.
Fan S, Hu Z, Hong H, Zhao F. Cross-cultural adaptation and validation of the simplified Chinese version of the Roland-Morris Disability Questionnaire. Spine. 2012;37(10):875–80.
Zhou X, Fang T. A verification study on the reliability and validity of Chinese translation of uterine fibroid symptoms and health-related quality of life. Nurs Practice Res. 2020;17(22):87–9.
Chen J, Li Y, Wang Z, McCulloch P, Hu L, Chen W, Liu G, Li J, Lang J. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploratory study . BJOG Int J Obstet Gynaecol. 2018;125(3):354–64.
Li J, Wang H. Assessment of the reliability and validity of the SF-36 scale (version 2) in urban residents – quality of life in Chongqing. J Fourth Mil Med Univ. 2009;30(14):1342–4.
Li L, Wang HM, Shen Y. Chinese SF-36 Health Survey: translation, cultural adaptation, validation and standardization. J Epidemiol Community Health. 2003;57(4):259–63.
Chang CY, Huang CK, Chang YY, Tai CM, Lin JT, Wang JD. Cross-validation of the Taiwanese version of the Moorehead-Ardelt Quality of Life Questionnaire II with WHOQOL and SF-36. Obés Surg. 2010;20(11):1568–74.
Ware J, Snoww K, Ma K, Bg G. SF36 Health Survey: Manual and Interpretation Guide. Lincoln: Quality Metric, Inc.; 1993. p. 30.
Coyne KS, Margolis MK, Murphy J, Spies J. Validation of the UFS-QOL-Hysterectomy questionnaire: modification of an existing measure for comparative efficacy research. Value health. 2012;15(5):674–9.
Coyne KS, Margolis MK, Bradley LD, Guido R, Maxwell GL, Spies JB. Further validation of the questionnaire on symptoms of uterine fibroids and quality of life. Value health. 2012;15(1):135–42.
Revicki DA, Cook KF, Amtmann D, Harnam N, Chen WH, Keefe FJ. Exploratory and confirmatory factor analysis of the PROMIS item bank on the quality of pain. Qual Life Res. 2014;23(1):245–55.
Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims
Cohen J, Cohen J, Cohen JW, Cohen J, Cohen J, Cohen J, Cohen J, Cohen JW, Cohen N, Cohen C. Statistical power analysis for behavioral science. Technometrics. 1988;31(4):499–500.
Ghanbari A, Hasandoost F, Lyili EK, Khomeiran RT, Momeni M. Assessing the clinical skills of emergency nurses: an exploratory factor analysis study. Iran J Nurs Midwifery Res. 2017;22(4):280–6.
Pourmovahed Z, Mahmoodabadi HZ, Ardekani SMY, Fallahzadeh H, Tavangar H, Mahmoodabad SSM. Validation of the Family Stability Questionnaire in married couples: a confirmatory factor analysis. Electron Phys. 2018;10(8):7185–95.
McHorney CA, Tarlov AR. Individual follow-up of patients in clinical practice: are the available health surveys sufficient? Qual Life Res. 1995;4(4):293–307.
Administration FaD: Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims, vol. 65132–65133. Federal Register: 74; 2009.
Pakpour AH, Zeidi IM, Saffari M, Burri A. Psychometric properties of the Iranian version of the Female Sex Life Quality Scale. J Sex Med. 2013;10(4):981–9.
Lyu J, Shen X, Hesketh T. Sexual knowledge, attitudes and behaviors among undergraduate students in China – implications for sex education. Int J Environ Res Public Health. 2020;17(18):6716.
Sun X, Li C, Jin L, Fan Y, Wang D. Development and validation of the Chinese version of the female sexual function index in a Chinese population – a pilot study. J Sex Med. 2011;8(4):1101–11.